Press Releases Events & Presentations Press Releases Year None2019201820172016201520142013201220112010 Apr 22, 2019 Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development View HTML PDF Version Apr 13, 2019 Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019 View HTML PDF Version Apr 11, 2019 Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019 View HTML PDF Version Mar 27, 2019 Assembly Biosciences Announces Multiple Abstracts Highlighting HBV Core Inhibitor Portfolio Accepted for Oral and Poster Presentations at EASL 2019 View HTML PDF Version Mar 13, 2019 Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit View HTML PDF Version Feb 28, 2019 Assembly Biosciences Reports Fourth Quarter and Year End 2018 Financial Results View HTML PDF Version Jan 07, 2019 Assembly Biosciences Announces Completion of Enrollment in Two Phase 2a Studies with ABI-H0731 for Chronic Hepatitis B Virus View HTML PDF Version Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None2019201820172016201520142013201220112010 Apr 22, 2019 Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development View HTML PDF Version Apr 13, 2019 Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019 View HTML PDF Version Apr 11, 2019 Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019 View HTML PDF Version Mar 27, 2019 Assembly Biosciences Announces Multiple Abstracts Highlighting HBV Core Inhibitor Portfolio Accepted for Oral and Poster Presentations at EASL 2019 View HTML PDF Version Mar 13, 2019 Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit View HTML PDF Version Feb 28, 2019 Assembly Biosciences Reports Fourth Quarter and Year End 2018 Financial Results View HTML PDF Version Jan 07, 2019 Assembly Biosciences Announces Completion of Enrollment in Two Phase 2a Studies with ABI-H0731 for Chronic Hepatitis B Virus View HTML PDF Version Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
